Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? (Q36144296)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
scientific article

    Statements

    Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? (English)
    Anke Lühe
    Laura Suter
    Stefan Ruepp
    Thomas Singer
    Thomas Weiser
    Silvio Albertini
    25 April 2005
    102-115

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit